Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Deep Brain Stimulation of the Fornix (DBSf) Shows Promise as Treatment for Patients with Mild Alzheimer's Disease
BOSTON, Nov 6, 2015/PRNewswire? -- Functional Neuromodulation Ltd. announced that an analysis of the ADvance Study, a Phase 2 double-blind... Read more
Invitae announces third quarter 2015 financial results and raises 2015 volume guidance
Invitae Corporation (NYSE:NVTA) today reported financial and operating results for the third quarter ended September 30, 2015. Read more